Skip to contents

NOEC, ECx, BMD, etc.

Source: vignettes/articles/NOEC_ECx_BMD.Rmd
NOEC_ECx_BMD.Rmd

Current Statistical Practices

Current statistical practices typically involve the following steps:

  1. Design Experimental Study (according to corresponding test guideline)
    • Define endpoints (survival, growth, reproduction, etc.)
    • Identify concentration range and replication
  2. Data Acquisition & Quality Check
    • Randomization and controls
    • Data integrity, outliers, missing values
  3. Exploratory Data Analysis
    • Plot response vs. dose
    • Assess data distribution and variance homogeneity
  4. NOEC Determination
    • Apply ANOVA/multiple comparisons (e.g., Dunnett’s) or sequential tests.
    • Identify highest dose without significant difference
  5. Dose–Response Modeling and ECx Calculation
    • Fit a model (e.g., logistic, probit, Weibull) to the data
    • Evaluate goodness-of-fit, possible data transformations
    • Derive ECx values (EC10, EC20, etc.) using the fitted model
    • Estimations and predictions if needed
  6. Uncertainty & Sensitivity Analysis
    • Confidence intervals for NOEC and ECx values
    • Comparison of model-based ECx estimates versus NOEC
  7. Regulatory Risk Assessment
    • Use NOEC or ECx values along with safety factors to define acceptable exposure limits

NOEC

  • Definition: The highest tested concentration at which no statistically significant adverse effect is observed relative to the control.
  • Regulatory Role: Historically used as the primary benchmark (e.g., for deriving acceptable daily intakes or environmental quality standards).

Strengths:

  • Straightforward concept and quick to interpret
  • Familiar to risk assessors and historically embedded in many regulatory frameworks

Weaknesses:

  • Strongly dependent on the dose spacing and study design
  • Does not provide information on the magnitude of effects or their progression along a dose–response curve
  • Binary interpretation (“effect” vs. “no effect”) can oversimplify data
  • Potentially influenced by low statistical power, especially in studies with small sample sizes

ECx and BMD

  • Definition: The concentration at which a predefined percentage (x) of effect (e.g., 10%, 20% reduction in a biological endpoint) is observed relative to the control.

  • Regulatory Role: Increasingly used to quantitatively describe the magnitude of adverse effects along the dose–response curve and considered more informative in deriving species sensitivity distributions.

Strengths:

  • Utilizes the full data set by modeling the dose–response relationship
  • Provides a more nuanced and continuous estimate along the effect continuum (e.g., EC10 is often seen as protective)
  • Facilitates interpolation and extrapolation within the tested range
  • Offers the possibility to quantify uncertainty via confidence intervals

Weaknesses:

  • Heavily dependent on the choice and fit of the dose–response model
  • Requires more sophisticated statistical methods and expertise
  • May be sensitive to violations of model assumptions if data quality or distribution is suboptimal
  • In some cases, different models may yield different ECx estimates, raising issues of model selection and validation

Methodological Improvements

Papers, scientific opinions, guidance are regularly published on methodological improvements in statistical evaluation of ecotoxicological studies.

  • We advocate for transparent reporting of uncertainties and assumptions in model selection or model averaging.
  • Integration of Bayesian methods and bootstrap techniques to better quantify uncertainty is emerging in research discussions.
  • Model averaging.

References